Anatara Lifesciences Ltd Stock price

Equities

ANR

AU000000ANR0

Biotechnology & Medical Research

Market Closed - Australian S.E. 12:46:43 2024-03-28 am EDT 5-day change 1st Jan Change
0.039 AUD -4.88% Intraday chart for Anatara Lifesciences Ltd 0.00% +77.27%
Sales 2022 - Sales 2023 - Capitalization 3.36M 2.18M
Net income 2022 -2M -1.3M Net income 2023 -2M -1.3M EV / Sales 2022 -
Net cash position 2022 1.1M 717K Net cash position 2023 401K 261K EV / Sales 2023 -
P/E ratio 2022
-1.54 x
P/E ratio 2023
-1.35 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 40.35%
More Fundamentals * Assessed data
Dynamic Chart
1 day-4.88%
Current month+56.00%
1 month+56.00%
3 months+77.27%
6 months+34.48%
Current year+77.27%
More quotes
1 week
0.04
Extreme 0.035
0.04
1 month
0.02
Extreme 0.024
0.04
Current year
0.02
Extreme 0.021
0.04
1 year
0.02
Extreme 0.021
0.05
3 years
0.02
Extreme 0.021
0.28
5 years
0.02
Extreme 0.021
0.55
10 years
0.02
Extreme 0.021
1.83
More quotes
Managers TitleAgeSince
Chief Executive Officer 63 19-01-22
Chief Operating Officer - -
Corporate Officer/Principal - 21-12-05
Members of the board TitleAgeSince
Chief Executive Officer 63 19-01-22
Chief Operating Officer - -
Director/Board Member - -
More insiders
Date Price Change Volume
24-03-28 0.039 -4.88% 128 557
24-03-27 0.041 -4.65% 316,429
24-03-26 0.043 +10.26% 361,538
24-03-25 0.039 0.00% 115,333
24-03-21 0.039 +11.43% 276,473

Delayed Quote Australian S.E., March 28, 2024 at 12:46 am EDT

More quotes
Anatara Lifesciences Ltd is a life sciences company. The Company is engaged in developing and commercializing evidence-based products for gastrointestinal health. It develops products for human and animal health. Its products include Gastrointestinal ReProgramming (GaRP), Detach, BONIFF, and ANR-pf. Its GaRP Product is a microbiome-targeted multi-component complementary medicine, which is designed to address the primary underlying factors associated with chronic gastrointestinal conditions, such as irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD). Detach is a non-antibiotic approach to aid in the control of diarrheal disease known as scour, which is developed using bromelain. BONIFF is a revised formulation which is applied to dry feed for piglets after weaning, reducing labor input, and simplifying the entire process. ANR-pf is an enriched formulation for poultry in water, designed to allow the full delivery of key additives in a quick and flexible dosing method.
More about the company
  1. Stock
  2. Equities
  3. Stock Anatara Lifesciences Ltd - Australian S.E.